CD38 and melanoma: Primary melanoma cell lines can inhibit the proliferation of CD4+ and CD8+ T cells through adenosine-dependent mechanisms; however, it has been found that the use of CD38 inhibitors can reverse this effect and restore T cell proliferation (45).